These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3262420)

  • 1. Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.
    Dillman RO; Johnson DE; Shawler DL; Koziol JA
    Cancer Res; 1988 Nov; 48(21):6097-102. PubMed ID: 3262420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical trials using an immunoconjugate of T101 and methotrexate in an athymic mouse/human T-cell tumor model.
    Shawler DL; Johnson DE; Sweet MD; Myers LJ; Tudor SD; Beidler DE; Koziol JA; Dillman RO
    J Biol Response Mod; 1988 Dec; 7(6):608-18. PubMed ID: 3265148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
    Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
    Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human T-cell tumor growth by T101-ricin A-chain in an athymic mouse model.
    Leonard JE; Johnson DE; Shawler DL; Dillman RO
    Cancer Res; 1988 Sep; 48(17):4862-7. PubMed ID: 3261627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
    Stastny JJ; Das Gupta TK
    Cancer Res; 1993 Dec; 53(23):5740-4. PubMed ID: 8242630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor activity of daunomycin conjugated with antigastric cancer monoclonal antibody MGb2.
    Li S; Zhang XY; Qiao TD; Chen XT; Zhang SY; Chen LJ
    Oncol Res; 1992; 4(11-12):447-53. PubMed ID: 1299375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
    Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumour effects using a combination of two antibodies conjugated to different drugs.
    Rowland AJ; McKenzie IF; Pietersz GA
    J Drug Target; 1994; 2(2):113-21. PubMed ID: 8069589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline immunoconjugates prepared by a site-specific linkage via an amino-dextran intermediate carrier.
    Shih LB; Goldenberg DM; Xuan H; Lu H; Sharkey RM; Hall TC
    Cancer Res; 1991 Aug; 51(16):4192-8. PubMed ID: 1868440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
    Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
    Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
    Kukita K
    Hokkaido Igaku Zasshi; 1990 May; 65(3):254-65. PubMed ID: 1696238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
    Shen WC; Ballou B; Ryser HJ; Hakala TR
    Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of CC49-doxorubicin immunoconjugates.
    Johnson DA; Briggs SL; Gutowski MC; Barton R
    Anticancer Res; 1995; 15(4):1387-93. PubMed ID: 7654026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity.
    Ogden JR; Leung K; Kunda SA; Telander MW; Avner BP; Liao SK; Thurman GB; Oldham RK
    Mol Biother; 1989; 1(3):170-4. PubMed ID: 2604916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.